CT-based radiomics improves survival prediction in colorectal liver metastases: beyond clinical scores - Report - MDSpire

CT-based radiomics improves survival prediction in colorectal liver metastases: beyond clinical scores

  • By

  • Angela Ammirabile

  • Gilda Matteucci

  • Francesco Fiz

  • Elisa Ragaini

  • Sofia Moroni

  • Ezio Lanza

  • Lara Cavinato

  • Jacopo Galvanin

  • Chiara Masci

  • Guido Costa

  • Andrea Laghi

  • Luca Viganò

  • Francesca Ieva

  • Guido Torzilli

  • June 17, 2026

  • 0 min

Share

Clinical Report: Radiomics from CT Imaging Enhances Prognostic Accuracy for Survival

Overview

This study investigates the use of radiomic features from CT imaging to improve prognostic accuracy for overall survival in patients with colorectal liver metastases (CRLM) undergoing liver resection.

Background

Colorectal liver metastases are a significant cause of morbidity and mortality, with a notable percentage of patients experiencing early recurrence post-surgery. Traditional prognostic models often fail to accurately predict outcomes.

Data Highlights

No numerical data or trial data provided in the source material.

Key Findings

['Radiomic features from both tumor and liver-tumor interface were analyzed for their prognostic value.', 'The combined clinical-radiomic model demonstrated improved prognostic accuracy compared to traditional clinical models.', 'Established prognostic scores, such as Fong, GAME, and RAS mutation clinical risk scores, were used for comparison.', 'The study included patients who underwent liver resection for CRLM from January 2010 to January 2020.', 'Secondary objectives included assessing the impact of the interval between CT scans and surgery on prognostic accuracy.']

Clinical Implications

The integration of radiomic analysis into clinical practice may enhance patient selection for liver resection in CRLM cases. This approach could lead to more personalized treatment strategies based on improved prognostic assessments.

Conclusion

The study highlights the potential of radiomics to refine prognostic evaluations in colorectal liver metastases, suggesting a shift towards more comprehensive models that incorporate imaging data.

Related Resources & Content

  1. European Radiology, 2024 -- Creation and assessment of a radiopathomics model for forecasting liver metastases in colorectal cancer patients
  2. European Radiology, 2026 -- Radiomics-based outcome prediction for irinotecan-TACE in colorectal liver metastases: advanced analysis from the prospective CIREL trial
  3. The ASCO Post, 2026 -- Deep-Learning CT Biomarker Predicts Survival Better Than Traditional Measures in Immunotherapy-Treated Advanced NSCLC
  4. PubMed, 2025 -- Metastatic colorectal cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up
  5. ScienceDirect, 2025 -- Systemic chemotherapy for patients with resectable or resected colorectal cancer liver metastases: An individual patient data meta-analysis
  6. Annals of Surgical Oncology, 2026 -- A Comparison of 11 Clinical Risk Scores for Prediction of Survival After Curative-Intent Resection of Colorectal Liver Metastases
  7. The ASCO Post — Deep-Learning CT Biomarker Predicts Survival Better Than Traditional Measures in Immunotherapy-Treated Advanced NSCLC
  8. Metastatic colorectal cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up - PubMed
  9. Systemic chemotherapy for patients with resectable or resected colorectal cancer liver metastases: An individual patient data meta-analysis - ScienceDirect
  10. A Comparison of 11 Clinical Risk Scores for Prediction of Survival After Curative-Intent Resection of Colorectal Liver Metastases | Annals of Surgical Oncology | Springer Nature Link

Original Source(s)

Related Content